Tag: Koki Sato
Takeda strengthens patient offering in India via availability of Kynteles
Takeda Pharma has introduced innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Colitis and Crohn's Disease. Kynteles is likely to benefit patients with a low risk of serious or opportunistic infections like Tuberculosis...................
Takeda India contributes ₹1.2 Crore to COVID-19 PM Cares Fund
The contribution to the PM Cares Fund aims to support patients and the Government to contain the spread of the disease.................
World Hemophilia Day: Takeda India stands united for hemophilia patients
While approximately 21,000 hemophilic patients are registered in India, the ongoing government support, standards of care have improved in the country......................
Takeda appoints new country head for India
Seasoned biopharmaceutical leader with over 17 years of experience across geographies, Koki Sato to lead Takeda’s business in India, ensuring patient access to highly innovative medicines.......................